Tasneem Abbas Ali, Luck Nasir Hassan
Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Karachi.
J Coll Physicians Surg Pak. 2017 Jan;27(1):8-12.
To determine the causes, characteristics and predictors of mortality in patients with acute-on-chronic liver failure (ACLF).
Cross-sectional study.
Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Karachi, from July 2014 to June 2016.
All patients with acute-on-chronic liver disease (ACLD) with ages > 12 were included. Patients with ACLF, as defined by the Asian Pacific Association for the Study of Liver (APASL, 2014) were identified. Predictors of mortality were identified using chi-square or Fisher's exact test.
Included in the study were 72 patients with mean age of 36.71 years, 46 (63.9%) being males. Among them, 61 developed ACLF. Commonest causes of chronic liver disease (CLD) were chronic viral hepatitis (37, 51.4%) and autoimmune hepatitis (14, 19.4%). Commonest causes of acute liver injury (ALI) were acute viral hepatitis (24, 33.3%) and drug induced liver injury (DILI) (17, 23.6%). Among those with ACLF, 24 (39.3%) patients died with median survival of 17.1 ±13.5 days. Mortality was significantly associated with Child Turcotte Pugh (CTP) score ≥13 (p=0.010), model for end-stage liver disease (MELD) score ≥30 (p=0.001), age >40 years (p=0.036), organ failures (OF) ≥3 (p <0.0001), portosystemic encephalopathy (PSE) (p <0.0001), renal failure (p <0.0001) and urosepsis (p <0.0001).
Acute viral hepatitis and DILI are commonest causes of ACLF. Mortality is high in ACLF patients having OF ≥3, CTP ≥13, MELD ≥30, age >40 years, PSE, renal failure and urosepsis.
确定慢加急性肝衰竭(ACLF)患者的死亡原因、特征及预测因素。
横断面研究。
2014年7月至2016年6月,卡拉奇信德泌尿与移植研究所胃肠肝病科。
纳入所有年龄>12岁的慢性肝病急性发作(ACLD)患者。根据亚太肝脏研究协会(APASL,2014年)的定义确定ACLF患者。采用卡方检验或Fisher精确检验确定死亡预测因素。
研究纳入72例患者,平均年龄36.71岁,男性46例(63.9%)。其中,61例发生ACLF。慢性肝病(CLD)最常见的病因是慢性病毒性肝炎(37例,51.4%)和自身免疫性肝炎(14例,19.4%)。急性肝损伤(ALI)最常见的病因是急性病毒性肝炎(24例,33.3%)和药物性肝损伤(DILI)(17例,23.6%)。在ACLF患者中,24例(39.3%)死亡,中位生存期为17.1±13.5天。死亡率与Child Turcotte Pugh(CTP)评分≥13(p=0.010)、终末期肝病模型(MELD)评分≥30(p=0.001)、年龄>40岁(p=0.036)、器官衰竭(OF)≥3(p<0.0001)、门体性脑病(PSE)(p<0.0001)、肾衰竭(p<0.0001)和泌尿道感染(p<0.0001)显著相关。
急性病毒性肝炎和DILI是ACLF最常见的病因。在OF≥3、CTP≥13、MELD≥30、年龄>40岁、PSE、肾衰竭和泌尿道感染的ACLF患者中死亡率较高。